Province Covers New Cystic Fibrosis Drug
Province Covers New Cystic Fibrosis Drug August 4, 2026 People in Saskatchewan living with cystic fibrosis (CF) are now eligible for Alyftrek, a medication that improves lung function. As of August 1st, coverage of Alyftrek is now available to CF patients ages six and older who meet the medical criteria. The drug is effective for patients
Province Covers New Cystic Fibrosis Drug Read More »